ELAN – Elanco Animal Health Incorporated
Elanco Animal Health IncorporatELAN
$23.13Name : Elanco Animal Health Incorporat
Sector : Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Mark. Cap: $11,499,496,448.00
EPSttm : -0.47
Elanco Animal Health Incorporat
$23.13
5.90%$1.45
ELAN — Price & Forward EBITDA
Forward EBITDA (M)
Float Short %
3.48
Margin Of Safety %
13
Put/Call OI Ratio
0.54
EPS Next Q Diff
0.16
EPS Last/This Y
1.51
EPS This/Next Y
0.13
Price
23.11
Target Price
29.46
Analyst Recom
1.41
Performance Q
3.35
Upside
-144.7%
Beta
1.85
Ticker: ELAN
of 1
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2026-03-02 | ELAN | 26.07 | 1.17 | 0.20 | 26245 |
| 2026-03-04 | ELAN | 24.42 | 1.13 | 0.13 | 26801 |
| 2026-03-05 | ELAN | 23.93 | 1.13 | 0.57 | 26768 |
| 2026-03-09 | ELAN | 23.94 | 1.13 | 4.46 | 27251 |
| 2026-03-10 | ELAN | 23.67 | 1.09 | 0.35 | 26618 |
| 2026-03-11 | ELAN | 23.47 | 1.09 | 0.36 | 26619 |
| 2026-03-12 | ELAN | 22.68 | 1.08 | 1.75 | 26632 |
| 2026-03-17 | ELAN | 25.18 | 1.09 | 0.13 | 26536 |
| 2026-03-18 | ELAN | 24.84 | 1.08 | 0.29 | 26668 |
| 2026-03-19 | ELAN | 25.12 | 1.07 | 0.48 | 26710 |
| 2026-03-20 | ELAN | 23.99 | 1.07 | 0.15 | 26742 |
| 2026-03-23 | ELAN | 24.45 | 0.56 | 0.04 | 16683 |
| 2026-03-24 | ELAN | 24.92 | 0.54 | 0.03 | 16897 |
| 2026-03-25 | ELAN | 25.46 | 0.53 | 0.21 | 17163 |
| 2026-03-26 | ELAN | 24.58 | 0.53 | 0.01 | 17175 |
| 2026-03-27 | ELAN | 23.12 | 0.54 | 0.03 | 17073 |
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2026-03-02 | ELAN | 26.08 | -6.4 | 443.0 | 1.04 |
| 2026-03-03 | ELAN | 24.88 | -6.3 | 426.3 | 1.04 |
| 2026-03-04 | ELAN | 24.42 | -6.3 | 613.9 | 1.04 |
| 2026-03-05 | ELAN | 23.94 | -6.6 | 613.0 | 1.04 |
| 2026-03-06 | ELAN | 23.36 | -6.6 | 611.2 | 1.04 |
| 2026-03-09 | ELAN | 23.95 | -6.6 | 634.9 | 1.04 |
| 2026-03-10 | ELAN | 23.68 | -6.6 | 617.7 | 1.04 |
| 2026-03-11 | ELAN | 23.46 | -6.6 | 618.6 | 1.04 |
| 2026-03-12 | ELAN | 22.67 | -6.6 | 607.1 | 1.04 |
| 2026-03-13 | ELAN | 22.96 | -6.6 | 628.7 | 1.04 |
| 2026-03-17 | ELAN | 25.12 | -6.4 | 657.9 | 1.04 |
| 2026-03-18 | ELAN | 24.85 | -6.6 | 616.5 | 1.04 |
| 2026-03-19 | ELAN | 25.13 | -6.6 | 417.8 | 1.04 |
| 2026-03-20 | ELAN | 23.98 | -6.9 | 399.5 | 1.04 |
| 2026-03-23 | ELAN | 24.46 | -6.9 | 420.4 | 1.04 |
| 2026-03-24 | ELAN | 24.90 | -6.9 | 420.0 | 1.04 |
| 2026-03-25 | ELAN | 25.49 | -6.9 | 421.5 | 1.04 |
| 2026-03-26 | ELAN | 24.58 | -6.9 | 402.4 | 1.04 |
| 2026-03-27 | ELAN | 23.11 | -6.9 | 395.0 | 1.04 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2026-03-02 | ELAN | 0.96 | -6.19 | 3.74 |
| 2026-03-03 | ELAN | 0.96 | -6.19 | 3.74 |
| 2026-03-04 | ELAN | 0.96 | -6.19 | 3.74 |
| 2026-03-05 | ELAN | 0.96 | -6.19 | 3.74 |
| 2026-03-06 | ELAN | 0.96 | -6.19 | 3.74 |
| 2026-03-09 | ELAN | 0.96 | -6.06 | 3.74 |
| 2026-03-10 | ELAN | 0.96 | -6.06 | 3.74 |
| 2026-03-11 | ELAN | 0.96 | -6.06 | 3.06 |
| 2026-03-12 | ELAN | 0.96 | -6.06 | 3.06 |
| 2026-03-13 | ELAN | 0.96 | -6.06 | 3.06 |
| 2026-03-17 | ELAN | 0.96 | -6.20 | 3.06 |
| 2026-03-18 | ELAN | 0.96 | -6.20 | 3.06 |
| 2026-03-19 | ELAN | 0.96 | -6.20 | 3.06 |
| 2026-03-20 | ELAN | 0.96 | -6.20 | 3.06 |
| 2026-03-23 | ELAN | 0.96 | -6.28 | 3.06 |
| 2026-03-24 | ELAN | 0.96 | -6.28 | 3.06 |
| 2026-03-25 | ELAN | 0.96 | -6.28 | 3.48 |
| 2026-03-26 | ELAN | 0.96 | -6.28 | 3.48 |
| 2026-03-27 | ELAN | 0.96 | -6.28 | 3.48 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
0.13
Avg. EPS Est. Current Quarter
0.34
Avg. EPS Est. Next Quarter
0.29
Insider Transactions
0.96
Institutional Transactions
-6.28
Beta
1.85
Average Sales Estimate Current Quarter
1287
Average Sales Estimate Next Quarter
1320
Fair Value
26.1
Quality Score
53
Growth Score
55
Sentiment Score
72
Actual DrawDown %
38.3
Max Drawdown 5-Year %
-78
Target Price
29.46
P/E
Forward P/E
19.75
PEG
1.62
P/S
2.44
P/B
1.76
P/Free Cash Flow
40.49
EPS
-0.47
Average EPS Est. Cur. Y
1.04
EPS Next Y. (Est.)
1.17
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
-4.92
Relative Volume
1.09
Return on Equity vs Sector %
-30.9
Return on Equity vs Industry %
-10.7
EPS 1 7Days Diff
EPS 1 30Days Diff
0.01
EBIT Estimation
395
◆
ELAN
Healthcare
$23.13
Swing / Pullback
Buy the dip on strong trends
WEAK
RSI
42.3
Range 1M
18.6%
Momentum Growth
Ride accelerating trends
WEAK
EPS Yr
9.9%
EPS NY
13.4%
52W%
76.8%
Long-Term Value
Quality companies, undervalued
WEAK
🟡 HOLD
+15% upside
Upside
+15%
Quality
53
MoS
13%
Elanco Animal Health IncorporatSector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Employees: 9400
Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals worldwide. The company offers pet health products, such as parasiticides, vaccines, and therapeutics that protect pets from fleas, ticks, and internal parasites under the Seresto, K-9 Advantage, Advantix, and Advocate trademarks; prescription parasiticide products, an over-the-counter treatments for the prevention and elimination of fleas and ticks under the Credelio Family, Interceptor Plus, Drontal family, and Drontal Plus; vaccines portfolio that provides differentiated prevention coverage for a number of important pet health risks; and therapeutics portfolio for the treatment of pain, otitis, cardiovascular, and dermatology indications, as well as osteoarthritis for dogs and cats under the Galliprant trademark. It also provides farm animal products that help farmers improve animal health and wellbeing, and raise livestock, such as cattle, swine, and poultry. In addition, the company offers medicated feed additives, injectable antibiotics, vaccines, insecticides and enzymes, and others under the Rumensin, Baytril, and Experior trademarks for cattle; and under the Maxiban and Monteban trademarks for the control and prevention of intestinal disease in poultry. Further, it offers other pet health products for cats and dogs under the Atopica, Milbemax, Onsior, and Tru Family trademarks; and other farm animal products for poultry, cattle, and swine under the AviPro, Catosal, Denagard, Hemicell, Pulmotil, and Surmax tradmarks. The company sells its products to third-party distributors and independent retailers; and directly to farm animal producers and veterinarians. Elanco Animal Health Incorporated was founded in 1954 and is headquartered in Indianapolis, Indiana.
ELAN
Latest News
—
Caricamento notizie per ELAN…
stock quote shares ELAN – Elanco Animal Health Incorporated Stock Price stock today
news today ELAN – Elanco Animal Health Incorporated stock forecast ,stock prediction 2023 2024 2025
marketwatch ELAN – Elanco Animal Health Incorporated yahoo finance google finance
stock history ELAN – Elanco Animal Health Incorporated invest stock market
stock prices ELAN premarket after hours
ticker ELAN fair value insiders trading